Providence St. Mary Regional Cancer Center — Walla Walla, Washington

Providence St. Mary Regional Cancer Center is a clinical research site located in Walla Walla, Washington, United States 99362.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Providence St. Mary Regional Cancer Center has participated in 8 clinical trials.

Therapeutic areas: Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Sponsors: Celgene, Hoffmann-La Roche, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Providence St. Mary Regional Cancer Center?

Providence St. Mary Regional Cancer Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Providence St. Mary Regional Cancer Center conducted?

Providence St. Mary Regional Cancer Center has 8 clinical trials on record. Their work covers Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Is Providence St. Mary Regional Cancer Center accredited by Crixeo Health?

Yes — Providence St. Mary Regional Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Providence St. Mary Regional Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.